Efficacy of chemotherapy after progression during or following PARPi exposure in ovarian cancer.

Autor: Xu-Vuillard A; Medical Oncology Department, Gustave Roussy, Villejuif; Sorbonne Université, Paris., Guerin-Charbonnel C; Department of Biostatistics and Analytics, Institut de Cancérologie de L'Ouest, Nantes., Bocquet F; Data Factory, Institut de Cancérologie de L'ouest, Nantes, France., Cheeseman S; Leeds Cancer Center, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Kubelac PM; The Oncology Institute Prof. Dr Ion Chiricuta, Kluj-Napoca, Romania., Zenatri M; Medical Oncology Department, Institut de Cancérologie de L'Ouest, Saint-Herblain., Hall G; Leeds Cancer Center, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Achimas-Cadariu P; The Oncology Institute Prof. Dr Ion Chiricuta, Kluj-Napoca, Romania; Medical Oncology Department, Institut de Cancérologie de L'Ouest, Saint-Herblain; Medical Oncology Department, Centre Leon Berard, Lyon, France; Oncology Evidence Network, IQVIA, London, UK; City Hospital, Timisoara, Romania; Medical Oncology Department, Institut de Cancérologie de L'Ouest, Angers, France; University of Medicine and Pharmacy Iuliu Hatieganu, Kluj-Napoca, Romania., Hanvic B; Medical Oncology Department, Centre Leon Berard, Lyon, France., Fenton H; Oncology Evidence Network, IQVIA, London, UK., Sturz-Lazăr AM; City Hospital, Timisoara, Romania., Augereau P; Medical Oncology Department, Institut de Cancérologie de L'Ouest, Angers, France., Ray-Coquard I; Medical Oncology Department, Centre Leon Berard, Lyon, France., Leary A; Medical Oncology Department, Gustave Roussy, Villejuif., Frenel JS; Medical Oncology Department, Institut de Cancérologie de L'Ouest, Saint-Herblain. Electronic address: jean-sebastien.frenel@ico.unicancer.fr.

Publikováno v: ESMO open [ESMO Open] 2024 Sep; Vol. 9 (9), pp. 103694. Date of Electronic Publication: 2024 Sep 03.